Salma Jabbour, MD on Phase 2 Study of Pembrolizumab plus Platinum Doublet Chemotherapy in NSCLC @SalmaJabbour1 @RutgersCancer #ASCO2020

Salma Jabbour, MD on Phase 2 Study of Pembrolizumab plus Platinum Doublet Chemotherapy in NSCLC @SalmaJabbour1 @RutgersCancer #ASCO2020

Cancer-News

4 weeks
25 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Salma Jabbour, MD @SalmaJabbour1 of Rutgers Cancer Institute of New Jersey @RutgersCancer discusses phase 2 Study of pembro plus platinum doublet chemotherapy and radiotherapy as first-line therapy for locally advanced NSCLC presented at this year's virtual ASCO.
Up Next Autoplay